2EDR
 
 | | Solution structure of the ig-like domain (3361-3449) of human obscurin | | Descriptor: | Obscurin | | Authors: | Kurosaki, C, Izumi, K, Yoshida, M, Hayashi, F, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | | Deposit date: | 2007-02-14 | | Release date: | 2007-08-14 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Solution structure of the ig-like domain (3361-3449) of human obscurin
To be Published
|
|
2EDW
 | |
2ENO
 | |
2ENY
 | | Solution structure of the ig-like domain (2735-2825) of human obscurin | | Descriptor: | Obscurin | | Authors: | Nagashima, K, Izumi, K, Yoshida, M, Hayashi, F, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | | Deposit date: | 2007-03-28 | | Release date: | 2007-10-02 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Solution structure of the ig-like domain (2735-2825) of human obscurin
To be Published
|
|
2EDO
 | | Solution structure of the first ig-like domain from human CD48 antigen | | Descriptor: | CD48 antigen | | Authors: | Nagashima, K, Nagashima, T, Yoshida, M, Hayashi, F, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | | Deposit date: | 2007-02-14 | | Release date: | 2007-08-14 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Solution structure of the first ig-like domain from human CD48 antigen
To be Published
|
|
2ENQ
 | | Solution structure of the C2 domain from human PI3-kinase p110 subunit alpha | | Descriptor: | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | | Authors: | Endo, H, Nagashima, T, Yoshida, M, Hayashi, F, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | | Deposit date: | 2007-03-28 | | Release date: | 2008-04-01 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Solution structure of the C2 domain from human PI3-kinase p110 subunit alpha
To be Published
|
|
2EO9
 | |
2EOB
 | | Solution structure of the second SH2 domain from rat PLC gamma-2 | | Descriptor: | 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2 | | Authors: | Sano, R, Hayashi, F, Nagashima, T, Yoshida, M, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | | Deposit date: | 2007-03-29 | | Release date: | 2008-04-01 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Solution structure of the second SH2 domain from rat PLC gamma-2
To be Published
|
|
2EO6
 | | Solution structure of the SH2 domain from mouse B-cell linker protein BLNK | | Descriptor: | B-cell linker protein | | Authors: | Sano, R, Hayashi, F, Kurosaki, C, Yoshida, M, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | | Deposit date: | 2007-03-29 | | Release date: | 2008-04-01 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Solution structure of the SH2 domain from mouse B-cell linker protein BLNK
To be Published
|
|
2EPA
 | |
2EQZ
 | | Solution structure of the first HMG-box domain from high mobility group protein B3 | | Descriptor: | High mobility group protein B3 | | Authors: | Qin, X.R, Kurosaki, C, Yoshida, M, Hayahsi, F, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | | Deposit date: | 2007-03-30 | | Release date: | 2008-04-01 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Solution structure of the first HMG-box domain from high mobility group protein B3
To be Published
|
|
2GQJ
 | |
2GQH
 | |
2GQI
 | |
2GSB
 | | Solution structure of the second SH2 domain of human Ras GTPase-activating protein 1 | | Descriptor: | Ras GTPase-activating protein 1 | | Authors: | Kurosaki, C, Suetake, T, Yoshida, M, Hayashi, F, Yokoyma, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | | Deposit date: | 2006-04-26 | | Release date: | 2007-05-01 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Solution structure of the second SH2 domain of human Ras GTPase-activating protein 1
To be Published
|
|
6KRO
 | | Tankyrase-2 in complex with RK-582 | | Descriptor: | 6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-4-fluoranyl-1-methyl-1'-(8-methyl-4-oxidanylidene-3,5,6,7-tetrahydropyrido[2,3-d]pyrimidin-2-yl)spiro[indole-3,4'-piperidine]-2-one, GLYCEROL, PHOSPHATE ION, ... | | Authors: | Niwa, H, Shirai, F, Sato, S, Tsumura, T, Okue, M, Shirouzu, M, Seimiya, H, Umehara, T. | | Deposit date: | 2019-08-22 | | Release date: | 2020-04-01 | | Last modified: | 2024-03-27 | | Method: | X-RAY DIFFRACTION (1.9 Å) | | Cite: | Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer.
J.Med.Chem., 63, 2020
|
|
7NCI
 | |
7NCH
 | |
7NCJ
 | |
7NCK
 | |
7NCG
 | |
7NCA
 | |
8OTD
 | |
8OTH
 | |
8OT6
 | |
